"Eight hundred" after watching feeling
Release time:
2022-03-11
After watching this movie, my heart surged with pride. As if through the screen, I saw these brave soldiers and national heroes with my own eyes. They awakened me with blood and life.
In this movie, there is no exact hero. To be exact, every fighter who fights to the end is a hero. The so-called "
800" , actually there are only 400 warriors. Faced with the "Turtle Shell Array " built by the Japanese army with thick iron plates, the soldiers resolutely chose to pick up the explosive bag and die with the enemy. Every soldier who shouted his name loudly and disappeared into the fog of blood accompanied by a boom is a fearless hero. At the beginning, the people in the British and American Concession on the other side of the Suzhou River watched the fire from the other side. The smoke of gunpowder filled their eyes, but they were still unguarded. They were very happy with feasting and singing. But there are worried people among them, who have been doing their best to provide as much help as possible to the soldiers on the other side of the river. As the war became more and more fierce, the situation of the soldiers affected the hearts of the common people. Countless citizens climbed onto the roof to look at the warehouse, and some bold citizens even ran to the south bank of the Suzhou River to watch. Everyone has seen that this battle is not only the battle of these 400 people, but also the battle of the whole Chinese nation. At the end of the movie
, the superior believed that they had been fighting hard for four days and four nights, which had attracted the attention of the western world. the political purpose of the "
battle" had been achieved and ordered them to withdraw to the concession. I sat on the chair and watched them break through with the rain of bullets. when I saw the blood mist splashing behind them, I suddenly saw Lu Xun's words in my mind: "those who live will vaguely see the faint hope in the pale red blood. The real warrior will move forward more vigorously. " Yes, in this blood, I really see hope, that hope through time and space, burning on the left side of my chest. These 800 people are really Chinese. They walked forward in the fog of blood and awakened the sleeping and numb people. Eight hundred, not only eight hundred people, but also eight hundred spirit. (Pan Zonghua)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31